FDA
approval
· 2013-11-15
FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
Summary
FDA approved a supplemental application for POMALYST (pomalidomide) by Celgene Corporation, expanding its approved use. This confirms regulatory approval for ch…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for POMALYST (POMALIDOMIDE)